A Prospective Cohort Study of Biomarkers in Squamous Cell Carcinoma of the Anal Canal (SCCAC) and their Influence on Treatment Outcomes von Moniz, Camila Motta Venchiarutti, Riechelmann, Rachel Pimenta, Oliveira, Suilane Coelho Ribeiro, Bariani, Giovanni Mendonça, Rivelli, Thomas Giollo, Ortega, Cintia, Pereira, Allan Andresson Lima, Meireles, Sibele Inácio, Franco, Rejane, Chen, Andre, Bonadio, Renata Colombo, Nahas, Caio, Sabbaga, Jorge, Coudry, Renata Almeida, Braghiroli, Maria Ignez, Hoff, Paulo Marcelo

Volltext

Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas von Ramella Munhoz, Rodrigo, de Mendonça Rego, Juliana Florinda, de Celis Ferrari, Anezka Rubim, Ignez Braghiroli, Maria, Mendonça Bariani, Giovanni, Marcelo Hoff, Paulo, Perego Costa, Frederico, Eduardo Flesch Pfiffer, Túlio, Riechelmann, Rachel

Volltext

Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label... von Romera, Alvaro, Peredpaya, Sergiy, Shparyk, Yaroslav, Bondarenko, Igor, Mendonça Bariani, Giovanni, Abdalla, Kathia Cristina, Roca, Enrique, Franke, Fábio, Melo Cruz, Felipe, Ramesh, Anita, Ostwal, Vikas, Shah, Pradeep, Rahuman, Sajeed Abdul, Paravisini, Alexandra, Huerga, Camino, Del Campo García, Ana, Millán, Susana

Volltext

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study von O'Malley, David M, Bariani, Giovanni Mendonca, Cassier, Philippe A, Marabelle, Aurelien, Hansen, Aaron R, De Jesus Acosta, Ana, Miller, Jr, Wilson H, Safra, Tamar, Italiano, Antoine, Mileshkin, Linda, Xu, Lei, Jin, Fan, Norwood, Kevin, Maio, Michele

Volltext

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study von Marabelle, Aurelien, Cassier, Philippe A, Fakih, Marwan, Kao, Steven, Nielsen, Dorte, Italiano, Antoine, Guren, Tormod Kyrre, van Dongen, Marloes G J, Spencer, Kristen, Bariani, Giovanni Mendonca, Ascierto, Paolo A, Santoro, Armando, Shah, Manisha, Asselah, Jamil, Iqbal, Syma, Takahashi, Shunji, Piha-Paul, Sarina A, Ott, Patrick A, Chatterjee, Arkendu, Jin, Fan, Norwood, Kevin, Delord, Jean-Pierre

Volltext

Regorafenib in antiangiogenic-naive, chemotherapy-refractory advanced colorectal cancer: A phase IIb trial von Riechelmann, Rachel Pimenta, Leite, Luiz Antonio Senna, Glasberg, Joao, Bariani, Giovanni Mendonca, Rivelli, Thomas Giollo, Nebuloni, Daniela R., Puty, Fabiola, Kappeler, Christian, Pereira, Kaline M. C., Queiroz, Marcelo A, Hoff, Paulo Marcelo

Volltext

Prospective study of biomarkers in squamous cell carcinoma of the anal canal (SCCAC) and their influence on treatment outcomes: Final results von Moniz, Camila Motta Venchiarutti, Riechelmann, Rachel Pimenta, Ribeiro, Suilane Coelho, Rivelli, Thomas Giollo, Bariani, Giovanni Mendonca, Chen, André, Franco, Rejane, Nahas, Caio, Pereira, Allan Andresson Lima, Ortega, Cintia, Sabbaga, Jorge, Meireles, Sibele, Coudry, Renata A., Hoff, Paulo Marcelo

Volltext

The expression profile of biomarkers in squamous cell carcinoma of the anal canal and their influence on treatment outcomes: Preliminary results von Moniz, Camila Motta Venchiarutti, Riechelmann, Rachel Pimenta, Ribeiro, Suilane Coelho, Bariani, Giovanni Mendonca, Rivelli, Thomas Giollo, Ortega, Cintia, Pereira, Allan Andresson Lima, Meireles, Sibele Inacio, Chen, André, Nahas, Caio, Sabagga, Jorge, Coudry, Renata A., Hoff, Paulo Marcelo

Volltext

Results of bevacizumab biosimilar compared with RMP for the treatment of metastatic colorectal cancer von Roca, Enrique Luis, Vinnyk, Yuriy, Bondarenko, Igor, Shparyk, Yaroslav V., Bariani, Giovanni Mendonca, Abdalla, Kathia, Franke, Fábio, Cruz, Felipe, Romera, Alvaro, Bhamare, Sulabhchandra, Sudalaiandi, Suresh, Ostwal, Vikas S., Shah, Pradeep, Rahuman, Sajeed, Cubillo, Antonio, Huerga, Camino, Paravisini, Alexandra, Fernandez, Francisco Javier, Millan, Susana

Volltext

Self-reported conflicts of interest (sfCOI) of authors and the interpretation of randomized phase III trials (RCT) and related editorials (REd) in cancer research von Bariani, Giovanni Mendonca, De Celis Ferrari, Anezka Carvalho Rubin, Hoff, Paulo Marcelo, Riechelmann, Rachel

Volltext

Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report von de Castria, Tiago Biachi, Tang, Laura, Queiroz, Marcello Moro, Awni, Beatriz Mendes, Paroder, Viktoriya, Shamseddine, Ali, Bariani, Giovanni Mendonca, Mukherji, Deborah, Matar, Charbel F, Fernandes, Gustavo Dos Santos, El-Olayan, Ashwaq, Sabatin, Fouad, Elias, Rawad, Gupta, Ranju, Janjigian, Yelena Y, Abou-Alfa, Ghassan K

Volltext

Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal von Ribeiro, Suilane Coelho, Moniz, Camila Motta Venchiarutti, Riechelmann, Rachel, Bariani, Giovanni Mendonca, Braghiroli, Maria Ignez, Nahas, Caio, Coudry, Renata, Alex, Alexandra Khichfy, Carneiro, Allyne Q., Nebuloni, Daniela R., Glasberg, Joao, Hoff, Paulo

Volltext

Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report von de Castria, Tiago Biachi, Tang, Laura, Queiroz, Marcello Moro, Awni, Beatriz Mendes, Paroder, Viktoriya, Shamseddine, Ali, Bariani, Giovanni Mendonca, Mukherji, Deborah, Matar, Charbel F, Fernandes, Gustavo Dos Santos, El-Olayan, Ashwaq, Sabatin, Fouad, Elias, Rawad, Gupta, Ranju, Janjigian, Yelena Y, Abou-Alfa, Ghassan K

Volltext